Beta test rollout. This site is in community QA — please send feature requests, bug reports and data corrections on the Feedback page or on GitHub.

Home
    Disclaimer
    πŸ§ͺ This is a research chemical with limited data on its long-term health effects, toxicity profile, and safe dosage ranges.

    Mirogabalin Encyclopedic
    Encyclopedic
    Typical encyclopedia coverage. Cross-reference for important decisions.
    • 2 corroborating sources
    • 1 ROA with full dose ladder
    • duration data present
    • 22 combo interactions documented
    • classified Research-chemical
    • dose data not in PW/TripSit (unverifiable)

    Aliases: Tarlige, Ds-5565, Mirogabalin besylate, Mirogabalin monobenzenesulfonate

    Summary dose.wiki

    Mirogabalin is approved in Japan and several Asian countries for diabetic peripheral neuropathic pain and postherpetic neuralgia. It has higher binding affinity and slower dissociation from Ξ±2Ξ΄-1 subunits compared to pregabalin, potentially offering improved analgesic effects with fewer CNS side effects. Dose adjustments are necessary for renal impairment: 50% reduction for moderate impairment (CrCl 30-60 mL/min) and 75% reduction for severe impairment.

    Dose Information source varies by band

    Dose basis. Ranges synthesized from clinical dosing in trials and class comparisons; non-medical use carries added risk. Start at the lowest end, especially if combining with other sedatives or if renal function is reduced. User reports are sparse; avoid redosing within 12 hours to limit cumulative sedation. (Dose figures and this note are from Drugs.Wiki.)

    ROA Light Common Strong Heavy
    Oral 5-10mg 10-30mg (5-10 mg BID) 30-40mg 40-50mg+
    Light Common Strong Heavy
    Sources· 1 of 1 ladders not fully identified

    Oral

    Dose ladder — Light: Drugs.Wiki · Common: not identified · Strong, Heavy: Drugs.Wiki

    Onset, Duration & After-effects dose.wiki Drugs.Wiki

    ROA Onset Comeup Peak Offset Total
    Oral 30-60 min 1-2 hrs 2-4 hrs 3-6 hrs 6.5-13 hrs

    Tolerance

    Build-up develops over 1–4 weeks of regular use
    Reset days to weeks depending on duration of use

    Tolerance Decay

    Full tolerance 14d Half tolerance 7d Baseline ~21d

    Tolerance builds with regular use over days to weeks, as with other gabapentinoids; waits of 1–3 weeks after cessation typically reduce tolerance significantly. Cross‑tolerance within the class is expected but not complete; data are class‑based and partly anecdotal.

    Cross-Tolerances

    Effects dose.wiki

    Positive
    Negative
    Neutral
    Positive
    Negative
    Positive
    Negative
    Neutral

    Combinations

    Cross-Check Mirogabalin with another substance

    Trip Reports Effect Index

    →

    Helpful Links

    Add to PsychonautWiki Journal

    The PsychonautWiki Journal logging app doesn't include every substance. To track Mirogabalin there, start adding an ingestion, search for the name, and choose to add it as a custom substance. Paste these values:

    ⬇ Download import file Import this file as custom substances and you get "Mirogabalin (Substance Search)" with every route's full dose ladder and timeline, no typing. Works on iOS and Android (v15+); the format is confirmed by the app's developer. The manual values below work for older versions.
    Name
    Mirogabalin
    Unit
    mg
    Description
    Mirogabalin
    Source: SubstanceSearch (substancesearch.com)
    
    Oral dose (mg): light 5-10 Β· common 10-30 (5-10  BID) Β· strong 30-40 Β· heavy 40-50+
    
    Oral duration: onset 0.5-1h Β· come-up 1-2h Β· peak 2-4h Β· offset 3-6h Β· total 6.5-13h
    
    Note: ranges are harm-reduction guidance, not a prescription. Start low, go slow, and test your substances.

    Tip: for quicker logging you can also add a Custom Unit in the app, e.g. common dose ~ 20 mg (Oral).

    The app keeps custom substances simple, so the full dose ranges live in the description text above. Ranges are harm-reduction guidance, not a prescription.